Position in XGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,342,966
New position
Shares Held
288,810
first reported quarter
Ownership
1.19%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 57 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 19%
Shared 0%
None 81%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $53,746,521 across 8 Diagnostics & Research names. XGN ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
67,484 | $33,833,778 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
14,882 | $7,834,480 | |
| 3 | A |
Agilent Technologies, Inc.
|
50,709 | $6,735,676 | |
| 4 | DHR |
Danaher Corp /De/
|
14,389 | $2,740,816 | |
| 5 | XGN |
Exagen Inc.
This page
|
288,810 | $1,342,966 | |
| 6 | WAT |
Waters Corp /De/
|
1,628 | $610,565 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,047 | $395,521 | |
| 8 | NTRA |
Natera, Inc.
|
931 | $252,719 |
All Filings in XGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,342,966 | 288,810 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||